Future research with larger sample sizes and more rigorous methodologies is needed to elucidate the exact role of TNF-α in the pathogenesis of this condition, to determine its potential as a biomarker for diagnosis, and to explore the potential therapeutic implications of targeting TNF-α in the management of DD. This evidence concerns the gene TNF and dentin dysplasia.